Oncology Central

Genetic and molecular targets in lymphoma: implications for prognosis and treatment

0

Lymphomas are the most common hematologic malignancies with approximately 79,000 new cases estimated for 2013 in the USA. Despite improved outcomes, relapse or recurrence remains a common problem with conventional cytotoxic therapy. Recently, many genetic and molecular mechanisms that drive various cellular events like apoptosis, angiogenesis and cell motility have been more clearly delineated.

To view restricted content, please:
Share:

Leave A Comment